{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:23:41Z","timestamp":1790727821142,"version":"4.1.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,12,9]],"date-time":"2016-12-09T00:00:00Z","timestamp":1481241600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Saf"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1007\/s40264-016-0487-9","type":"journal-article","created":{"date-parts":[[2016,12,9]],"date-time":"2016-12-09T10:39:21Z","timestamp":1481279961000},"page":"249-255","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":61,"title":["Melanoma and Non-Melanoma Skin Cancer Associated with Angiotensin-Converting-Enzyme Inhibitors, Angiotensin-Receptor Blockers and Thiazides: A Matched Cohort Study"],"prefix":"10.1007","volume":"40","author":[{"given":"Beatrice","family":"Nardone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Majewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley S.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Kiguradze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estela M.","family":"Martinez-Escala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rivka","family":"Friedland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Amin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne E.","family":"Laumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice J.","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfred W.","family":"Rademaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary C.","family":"Martini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis P.","family":"West","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,12,9]]},"reference":[{"issue":"9460","key":"487_CR1","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0140-6736(05)70937-5","volume":"365","author":"JF Thompson","year":"2005","unstructured":"Thompson JF, Scolyer RA, Kefford RF. Cutaneous melanoma. Lancet. 2005;365(9460):687\u2013701.","journal-title":"Lancet"},{"issue":"9715","key":"487_CR2","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0140-6736(09)61196-X","volume":"375","author":"V Madan","year":"2010","unstructured":"Madan V, Lear JT, Szeimies RM. Non-melanoma skin cancer. Lancet. 2010;375(9715):673\u201385.","journal-title":"Lancet"},{"issue":"9","key":"487_CR3","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1038\/sj.bjc.6604686","volume":"99","author":"AO Jensen","year":"2008","unstructured":"Jensen AO, Thomsen HF, Engebjerg MC, Olesen AB, Sorensen HT, Karagas MR. Use of photosensitising diuretics and risk of skin cancer: a population-based case-control study. Br J Cancer. 2008;99(9):1522\u20138.","journal-title":"Br J Cancer"},{"issue":"5","key":"487_CR4","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.canep.2009.10.005","volume":"33","author":"ER Koomen","year":"2009","unstructured":"Koomen ER, Herings RM, Guchelaar HJ, Nijsten T. Melanoma incidence and exposure to angiotensin-converting enzyme inhibitors and angiotensin receptor blockers. Cancer Epidemiol. 2009;33(5):391\u20135.","journal-title":"Cancer Epidemiol."},{"issue":"8","key":"487_CR5","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1111\/jdv.12921","volume":"29","author":"SA Schmidt","year":"2015","unstructured":"Schmidt SA, Schmidt M, Mehnert F, Lemeshow S, Sorensen HT. Use of antihypertensive drugs and risk of skin cancer. J Eur Acad Dermatol Venereol. 2015;29(8):1545\u201354.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"14","key":"487_CR6","doi-asserted-by":"crossref","first-page":"E1073","DOI":"10.1503\/cmaj.101497","volume":"183","author":"C Yoon","year":"2011","unstructured":"Yoon C, Yang HS, Jeon I, Chang Y, Park SM. Use of angiotensin-converting-enzyme inhibitors or angiotensin-receptor blockers and cancer risk: a meta-analysis of observational studies. CMAJ. 2011;183(14):E1073\u201384.","journal-title":"CMAJ"},{"issue":"7","key":"487_CR7","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S1470-2045(10)70106-6","volume":"11","author":"I Sipahi","year":"2010","unstructured":"Sipahi I, Debanne SM, Rowland DY, Simon DI, Fang JC. Angiotensin-receptor blockade and risk of cancer: meta-analysis of randomised controlled trials. Lancet Oncol. 2010;11(7):627\u201336.","journal-title":"Lancet Oncol."},{"key":"487_CR8","unstructured":"US Food and Drug Administration (FDA). FDA Drug Safety Communication: No Increase in Risk of Cancer with Certain Blood Pressure Drugs\u2013Angiotensin Receptor Blockers (ARBs). 2011. http:\/\/www.fda.gov\/Drugs\/DrugSafety\/ucm257516.htm#sa . Accessed 9 Aug 2016."},{"issue":"2","key":"487_CR9","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1080\/02841860310022346","volume":"43","author":"H Lindberg","year":"2004","unstructured":"Lindberg H, Nielsen D, Jensen BV, Eriksen J, Skovsgaard T. Angiotensin converting enzyme inhibitors for cancer treatment? Acta Oncol. 2004;43(2):142\u201352.","journal-title":"Acta Oncol"},{"issue":"5","key":"487_CR10","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s40264-013-0042-x","volume":"36","author":"JM McKoy","year":"2013","unstructured":"McKoy JM, Fisher MJ, Courtney DM, Raisch DW, Edwards BJ, Scheetz MH, et al. Results from the first decade of research conducted by the Research on Adverse Drug Events and Reports (RADAR) project. Drug Saf. 2013;36(5):335\u201347.","journal-title":"Drug Saf"},{"issue":"4","key":"487_CR11","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/cts.12294","volume":"8","author":"JB Starren","year":"2015","unstructured":"Starren JB, Winter AQ, Lloyd-Jones DM. Enabling a learning health system through a unified enterprise data warehouse: the Experience of the Northwestern University Clinical and Translational Sciences (NUCATS) Institute. Clin Transl Sci. 2015;8(4):269\u201371.","journal-title":"Clin Transl Sci."},{"issue":"10","key":"487_CR12","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1097\/00007890-200011270-00015","volume":"70","author":"L Naldi","year":"2000","unstructured":"Naldi L, Fortina AB, Lovati S, Barba A, Gotti E, Tessari G, et al. Risk of nonmelanoma skin cancer in Italian organ transplant recipients. A registry-based study. Transplantation. 2000;70(10):1479\u201384.","journal-title":"Transplantation."},{"issue":"5","key":"487_CR13","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis. 1987;40(5):373\u201383.","journal-title":"J Chron Dis."},{"issue":"6","key":"487_CR14","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0895-4356(92)90133-8","volume":"45","author":"RA Deyo","year":"1992","unstructured":"Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45(6):613\u20139.","journal-title":"J Clin Epidemiol"},{"key":"487_CR15","unstructured":"Agresti A. Categorical data analysis, 3rd ed. Hoboken: Wiley; 2013."},{"key":"487_CR16","unstructured":"Basal and squamous cell skin cancer risk factors [Internet]. [cited 9 Aug 2016]. http:\/\/www.cancer.org\/cancer\/skincancer-basalandsquamouscell\/detailedguide\/skin-cancer-basal-and-squamous-cell-risk-factors . Accessed 9 Aug 2016."},{"key":"487_CR17","unstructured":"SEER Stat Fact Sheets: Melanoma of the Skin [Internet]. [cited 9 Aug 2016]. Available from: http:\/\/seer.cancer.gov\/statfacts\/html\/melan.html . Accessed 9 Aug 2016."},{"key":"487_CR18","unstructured":"SAS Institute Inc. SAS OnlineDoc\u00ae 9.4. Cary: SAS Institute Inc; 2012."},{"issue":"6","key":"487_CR19","doi-asserted-by":"crossref","first-page":"439","DOI":"10.5414\/CNP73439","volume":"73","author":"L Moscarelli","year":"2010","unstructured":"Moscarelli L, Zanazzi M, Mancini G, Rossi E, Caroti L, Rosso G, et al. Keratinocyte cancer prevention with ACE inhibitors, angiotensin receptor blockers or their combination in renal transplant recipients. Clin Nephrol. 2010;73(6):439\u201345.","journal-title":"Clin Nephrol"},{"issue":"17","key":"487_CR20","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1093\/jnci\/djn262","volume":"100","author":"JB Christian","year":"2008","unstructured":"Christian JB, Lapane KL, Hume AL, Eaton CB, Weinstock MA, Trial V. Association of ACE inhibitors and angiotensin receptor blockers with keratinocyte cancer prevention in the randomized VATTC trial. J Natl Cancer Inst. 2008;100(17):1223\u201332.","journal-title":"J Natl Cancer Inst"},{"issue":"8","key":"487_CR21","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1158\/1055-9965.EPI-14-0251","volume":"23","author":"E McDonald","year":"2014","unstructured":"McDonald E, Freedman DM, Alexander BH, Doody MM, Tucker MA, Linet MS, et al. Prescription diuretic use and risk of basal cell carcinoma in the nationwide U.S. radiologic technologists cohort. Cancer Epidemiol Biomark Prev. 2014;23(8):1539\u201345.","journal-title":"Cancer Epidemiol Biomark Prev."},{"key":"487_CR22","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0378-4274(98)00237-9","volume":"102\u2013103","author":"RS Stern","year":"1998","unstructured":"Stern RS. Photocarcinogenicity of drugs. Toxicol Lett. 1998;102\u2013103:389\u201392.","journal-title":"Toxicol Lett"},{"issue":"14","key":"487_CR23","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1096\/fj.03-0129com","volume":"17","author":"T Walther","year":"2003","unstructured":"Walther T, Menrad A, Orzechowski HD, Siemeister G, Paul M, Schirner M. Differential regulation of in vivo angiogenesis by angiotensin II receptors. FASEB J. 2003;17(14):2061\u20137.","journal-title":"FASEB J."}],"container-title":["Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-016-0487-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40264-016-0487-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-016-0487-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T05:35:31Z","timestamp":1498368931000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40264-016-0487-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,9]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["487"],"URL":"https:\/\/doi.org\/10.1007\/s40264-016-0487-9","relation":{},"ISSN":["0114-5916","1179-1942"],"issn-type":[{"value":"0114-5916","type":"print"},{"value":"1179-1942","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,9]]}}}